Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Stem cell engineering and CRISPR were used to create mice with two male parents. Could we use this technique on humans?

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Researchers use CRISPR to overcome seemingly insurmontable reproductive barriers — but that doesn't mean this could work for ...

Grafting patches of lab-grown muscle to the surface of the heart could offer a lifeline for people waiting for a transplant.

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...